Arda Guler
Overview
Explore the profile of Arda Guler including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
46
Citations
101
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Yildirim Karakan C, Guler A, Tanboga I, Birant A, Uygur B, Zencirkiran Agus H, et al.
Turk Kardiyol Dern Ars
. 2025 Mar;
53(2):107-112.
PMID: 40035256
Objective: Mitral regurgitation (MR) is a critical determinant in patients with hypertrophic cardiomyopathy (HCM). Three-dimensional (3D) echocardiography has transformed the imaging of the mitral valve by enabling real-time, direct visualization....
2.
Tekin M, Babur Guler G, Cicek M, Tanboga I, Pysz P, Guler A, et al.
Catheter Cardiovasc Interv
. 2025 Feb;
PMID: 39980355
Background: Clinically significant paravalvular leak (PVL) may complicate both surgical and transcatheter valve implantation. Percutaneous PVL closure (PPVLC) is becoming an increasingly attractive alternative to redo surgery, with demonstrated lower...
3.
Kocabas U, Ergin I, Sonmez S, Yavuz V, Murat S, Ozdemir I, et al.
Clin Cardiol
. 2025 Jan;
48(1):e70088.
PMID: 39871620
Objective: The main objective of this study is to determine the incidence and predictors of clinical outcomes in patients with AF treated with factor Xa inhibitors in a real-world setting....
4.
Guler A, Erata Y, Demirtola A, Turkmen I, Atmaca S, Sahin H, et al.
Int J Cardiol
. 2024 Dec;
421():132913.
PMID: 39706304
Background: Hypertrophic cardiomyopathy (HCM) is characterized by left ventricular outflow tract obstruction (LVOTO), leading to symptoms and adverse outcomes. Disopyramide, with its negative inotropic effects, is commonly used to reduce...
5.
Babur Guler G, Gursoy M, Tan Kurklu T, Yakar Tuluce S, Karaca Ozer P, Karabulut D, et al.
Turk Kardiyol Dern Ars
. 2024 Nov;
52(Suppl. 1):1-206.
PMID: 39499904
Cardiomyopathy, which is shortly defined as a disease of the myocardium, has a broad definition that includes many different diagnoses. Recent advances in cardiac imaging techniques, including basic and advanced...
6.
Atmaca S, Guler A, Turkmen I, Sahin H, Babur Guler G
Turk Kardiyol Dern Ars
. 2024 Oct;
52(7):527-531.
PMID: 39397404
There is an increasing incidence of diagnosing both congenital and acquired heart valve diseases in women during pregnancy. Factors such as elevated rates of pregnancy, older maternal age, and coexisting...
7.
Tukenmez Karakurt S, Karakurt H, Guler A, Kadirogullari E, Aydin S, Babur Guler G
Turk Kardiyol Dern Ars
. 2024 Jul;
52(5):365-366.
PMID: 38982821
No abstract available.
8.
Babur Guler G, Guler A, Tanboga I, Turkmen I, Atmaca S, Sahin H, et al.
Echocardiography
. 2024 Jul;
41(7):e15880.
PMID: 38979714
Background: Left ventricular hypertrophy (LVH), including hypertensive LVH, hypertrophic cardiomyopathy (HCM) and cardiac amyloidosis (CA), is a commonly encountered condition in cardiology practice, presenting challenges in differential diagnosis. In this...
9.
Bozyel S, Simsek E, Burunkaya D, Guler A, Korkmaz Y, Seker M, et al.
Anatol J Cardiol
. 2024 Jun;
28(7):373.
PMID: 38940411
No abstract available.
10.
Dogan R, Saygi M, Birdal O, Gulcu O, Babur Guler G, Seker M, et al.
Acta Cardiol
. 2024 Feb;
79(9):995-1003.
PMID: 38357910
No abstract available.